Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study

Clinic Abstract Objective To examine the degree to which use of β blockers, statins, and diuretics in patients with Conclusions Among people with impaired glucose tolerance and other cardiovascular risk factors and with serial glucose measurements, diuretics and statins were associated with an increased risk of new onset diabetes, whereas the effect of β blockers was non-significant.

• Publication year

  2014

• Venue

  British medical journal

• Publication date

  2014-02-04

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1136/bmj.g1339PMCID 4590033
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.

  2012cited by this paper
• Dynamic marginal structural modeling to evaluate the comparative effectiveness of more or less aggressive treatment intensification strategies in adults with type 2 diabetes

  2012cited by this paper
• Effect of valsartan on the incidence of diabetes and cardiovascular events.

  2010cited by this paper
• Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.

  2010cited by this paper
• Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

  2010cited by this paper
• Effect of nateglinide on the incidence of diabetes and cardiovascular events.

  2010cited by this paper
• Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis

  2009cited by this paper
• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

  2008cited by this paper
• Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute.

  2008cited by this paper
• Antihypertensive Medications and the Risk of Incident Type 2 Diabetes

  2006cited by this paper
• Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  2006cited by this paper
• Prevention of Cardiovascular Events With an Antihypertensive Regimen of Amlodipine Adding Perindopril as Required Versus Atenolol Adding Bendroflumethiazide as Required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A Multicentre Randomised Controlled Tri

  2006cited by this paper
• Pravastatin and the Development of Diabetes Mellitus: Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study

  2001cited by this paper
• Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

  2000cited by this paper
• Marginal Structural Models and Causal Inference in Epidemiology

  2000cited by this paper
• Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus

  2000cited by this paper
• Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

  1999cited by this paper
• Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

  1999cited by this paper
• Method for conducting sensitivity analysis.

  1999cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Diabetes mellitus in treated hypertension: incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in the Primary Prevention Trial Göteborg, Sweden.

  1994cited by this paper
• Antihypertensive Drug Therapy and the Initiation of Treatment for Diabetes Mellitus

  1993cited by this paper
• High blood pressure and the incidence of non-insulin dependent diabetes mellitus: Findings in A 11.5 year follow-up study in the Netherlands

  1993cited by this paper
• Do antihypertensive drugs precipitate diabetes in predisposed men?

  1989cited by this paper
• Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension.

  1981cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Evaluating intensive blood pressure control versus usual care on cardiovascular disease in patients with diabetes using win statistics: a subgroup analysis of a cluster randomized trial.

  2025cites this paper
• A Mendelian randomization analysis of cardiac MRI measurements as surrogate outcomes for heart failure and atrial fibrillation

  2025cites this paper
• Helical‐Like Assembly of Nateglinide as Coating for Oral Delivery of Insulin and Their Synergistic Prevention of Diabetes Mellitus

  2023cites this paper
• An overview of the effects of combination therapy with a renin-angiotensin system blocker plus a calcium channel blocker on glucose homeostasis in non-diabetic hypertensive patients

  2022cites this paper
• VHRM_A_285907 337..348

  2021cites this paper
• Discordances between pediatric and adult thresholds in the diagnosis of hypertension in adolescents with CKD

  2021cites this paper
• β-Blockade for Patients with Hypertension, Ischemic Heart Disease or Heart Failure: Where are We Now?

  2021cites this paper
• Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease

  2021cites this paper
• Cardiovascular disease and risk of incident diabetes mellitus: Findings from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

  2021influential citation
• Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of Huanglian Jiedu Decoction in Treating Atherosclerosis

  2021cites this paper
• Diabetes knowledge among non-diabetic hypertensive patients in Calabar, Nigeria

  2020cites this paper
• Common drugs as micronutrient disruptors: A selection for clinical practice

  2020cites this paper
• Development and Validation of a Nomogram to Predict Type 2 Diabetes Mellitus in Overweight and Obese Adults: A Prospective Cohort Study from 82938 Adults in China

  2020cites this paper
• Comparison of real-world effectiveness between valsartan and non-RAS inhibitor monotherapy on the incidence of new diabetes in Chinese hypertensive patients: An electronic health recording system based study

  2019cites this paper
• Apparent therapy-resistant hypertension as risk factor for the development of type 2 diabetes mellitus.

  2019cites this paper
• The chemical exposome of type 2 diabetes mellitus: Opportunities and challenges in the omics era.

  2019cites this paper
• Manidipine: an antihypertensive drug with positive effects on metabolic parameters and adrenergic tone in patients with diabetes

  2018cites this paper
• Editor’s Pick: How Can We Develop More Effective Strategies for Type 2 Diabetes Mellitus Prevention? A Paradigm Shift from a Glucose-Centric to a Beta Cell-Centric Concept of Diabetes

  2018cites this paper
• Important drug-micronutrient interactions: A selection for clinical practice

  2018cites this paper
• Effect of statins on fasting glucose in non-diabetic individuals: nationwide population-based health examination in Korea

  2018cites this paper
• Heart failure and inflammation-related biomarkers as predictors of new-onset diabetes in the general population.

  2018cites this paper
• Application of causal inference methods in the analyses of randomised controlled trials: a systematic review

  2018cites this paper
• Synergistic effect of renalase and chronic kidney disease on endothelin-1 in patients with coronary artery disease ‒ a cross-sectional study

  2018cites this paper
• Defining and characterizing the critical transition state prior to the type 2 diabetes disease

  2017cites this paper
• Verapamil Use Is Associated With Reduction of Newly Diagnosed Diabetes Mellitus

  2017cites this paper
• Maintenance of negative fluid balance can improve endothelial and cardiac functions in primary hypertensive patients

  2017cites this paper
• 2016 Consensus statement on prevention of atherosclerotic cardiovascular disease in the Hong Kong population.

  2017cites this paper
• Overexpression of Toll-Like Receptors 2, 3, 4, and 8 Is Correlated to the Vascular Atherosclerotic Process in the Hyperlipidemic Rabbit Model: The Effect of Statin Treatment

  2017cites this paper
• OTHER SPECIFIC TYPES OF DIABETES

  2017cites this paper
• Potassium measurements and risk of type 2 diabetes: a dose-response meta-analysis of prospective cohort studies

  2017cites this paper
• Medications affecting glycemic control

  2017cites this paper
• Prediction of basal glycaemia dynamics during treatment with 6-month lipid-lowering therapy in patients at high risk of cardiovascular disease

  2017cites this paper
• THE RISK OF HYPERGLYCEMIA ASSOCIATED WITH THE USE OF PRESCRIBED MEDICATIONS

  2017cites this paper
• Safety issues related to the use of prescription drugs in patients with chronic diseases: a bibliographic review

  2017cites this paper
• Association of statins with diabetes mellitus and diabetic complications: role of confounders during follow-up

  2016cites this paper
• Interpretation of the evidence for the efficacy and safety of statin therapy.

  2016cites this paper
• Medication‐induced diabetes mellitus

  2016cites this paper
• Ankle-brachial index and incident diabetes mellitus: the atherosclerosis risk in communities (ARIC) study

  2016cites this paper
• Statin use and the risk of developing diabetes: a network meta‐analysis

  2016cites this paper
• Statin Dose and the Risk of Intracerebral Hemorrhage: A Population-Based Longitudinal Study in Taiwan.

  2016cites this paper
• Statins and risk for new-onset diabetes mellitus

  2016cites this paper
• Effect of oral antihypertensive drugs on biochemical dosages in the elderly

  2016cites this paper
• Low-density-lipoprotein cholesterol concentrations and risk of incident diabetes: epidemiological and genetic insights from the Framingham Heart Study

  2015cites this paper
• Statins and diabetes risk: how real is it and what are the mechanisms?

  2015cites this paper
• A COMPARATIVE STUDY OF THE EFFECTS OF THE ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS ON THE CARDIOVASCULAR OUTCOME IN HYPERTENSIVE PATIENTS WITH TYPE-2 DIABETES MELLITUS

  2015cites this paper
• Hyperglykämiemanagement in der Notaufnahme

  2015cites this paper
• Effect of nebivolol or nebivolol/hydrochlorothiazide plus atorvastatin on glycemic profile in patients with hypertension and dyslipidemia

  2015cites this paper
• Statine und erhöhte Inzidenz an Diabetes – Was ist in der Praxis zu beachten?

  2015cites this paper
• Primary hypertension is a disease of premature vascular aging associated with neuro-immuno-metabolic abnormalities

  2015cites this paper
• Statin use in prediabetic patients: rationale and results to date

  2015cites this paper
• Antihypertensive Drug Use and New-Onset Diabetes in Female Patients with Coronary Artery Disease

  2015cites this paper
• Using clinical data, hypothesis generation tools and PubMed trends to discover the association between diabetic retinopathy and antihypertensive drugs

  2015cites this paper
• Drug-Induced Hyperglycaemia and Diabetes

  2015cites this paper
• Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders

  2015cites this paper
• Diuretics and Bioimpedance‐Measured Fluid Spaces in Hypertensive Patients

  2014cites this paper
• Antihypertensive drugs and glucose metabolism.

  2014cites this paper
• Statins and breast cancer prognosis: evidence and opportunities.

  2014cites this paper
• Can We Stratify Cardiovascular Risk in Argentina

  2014cites this paper
• ¿Podemos estratificar el riesgo cardiovascular en la población argentina?

  2014cites this paper
• A randomised controlled trial for the evaluation of risk for type 2 diabetes in hypertensive patients receiving thiazide diuretics: Diuretics In the Management of Essential hypertension (DIME) study

  2014cites this paper
• Therapy and clinical trials.

  2014cites this paper
• Statins impair glucose uptake in human cells

  2014cites this paper